Last: | $0.384 |
---|---|
Change Percent: | 0.0% |
Open: | $0.3724 |
Close: | $0.384 |
High: | $0.39 |
Low: | $0.3613 |
Volume: | 145,041 |
Last Trade Date Time: | 02/17/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.384 | $0.3724 | $0.384 | $0.39 | $0.3613 | 145,041 | 02-20-2023 |
$0.384 | $0.3724 | $0.384 | $0.39 | $0.3613 | 145,040 | 02-17-2023 |
$0.3839 | $0.35 | $0.3839 | $0.394 | $0.35 | 267,899 | 02-16-2023 |
$0.394 | $0.4 | $0.394 | $0.4 | $0.378 | 130,809 | 02-15-2023 |
$0.3898 | $0.37 | $0.3898 | $0.39 | $0.36 | 122,173 | 02-14-2023 |
$0.37 | $0.4 | $0.37 | $0.4 | $0.35 | 324,698 | 02-13-2023 |
$0.4 | $0.41 | $0.4 | $0.42 | $0.395801 | 238,585 | 02-10-2023 |
$0.4098 | $0.4299 | $0.4098 | $0.4299 | $0.3999 | 166,993 | 02-09-2023 |
$0.4 | $0.4074 | $0.4 | $0.43 | $0.3997 | 263,708 | 02-08-2023 |
$0.42 | $0.424 | $0.42 | $0.4325 | $0.395 | 408,210 | 02-07-2023 |
$0.424 | $0.41 | $0.424 | $0.44 | $0.369 | 759,061 | 02-06-2023 |
$0.401 | $0.39 | $0.401 | $0.4091 | $0.39 | 324,462 | 02-03-2023 |
$0.4 | $0.3831 | $0.4 | $0.4029 | $0.38 | 926,834 | 02-02-2023 |
$0.38 | $0.38 | $0.38 | $0.4028 | $0.3799 | 707,194 | 02-01-2023 |
$0.38 | $0.3839 | $0.38 | $0.3839 | $0.34645 | 1,039,478 | 01-31-2023 |
$0.3254 | $0.2993 | $0.3254 | $0.3359 | $0.2993 | 397,028 | 01-30-2023 |
$0.2993 | $0.3 | $0.2993 | $0.3027 | $0.290101 | 287,171 | 01-27-2023 |
$0.295 | $0.29 | $0.295 | $0.3 | $0.2851 | 281,009 | 01-26-2023 |
$0.29 | $0.2725 | $0.29 | $0.29 | $0.2725 | 201,264 | 01-25-2023 |
$0.2769 | $0.28 | $0.2769 | $0.28 | $0.2742 | 114,725 | 01-24-2023 |
News, Short Squeeze, Breakout and More Instantly...
IsoRay Inc. Company Name:
ISR Stock Symbol:
NYSE Market:
RICHLAND, Wash. and CORALVILLE, Iowa, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (formerly known as Isoray, Inc.) (NYSE AMERICAN: ISR), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed b...
C omp any’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies New corporate tagline and website introduced N ew ticker symbol to be NYSE American: CATX RICHLAND,...
The combination delivers the promise of bringing powerful new perspectives to the rapidly emerging field of Alpha-Particle radiopharmaceuticals Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced the successful complet...